Neva Sgr. — 2024 Investments
3 investments dated 2024 · listed companies and verified rows first · show all
BetaGlue develops solutions for the medical device and healthcare sector, supported by a board of directors with expertise in interventional radiology, nuclear medicine, and clinical operations.
BiotechHealthtechMedical DevicesItaly, IT
BoardAlexis Peyroles(Chairman)
Co-investorsLIFTTInnogest CapitalPanakes Partners
Cool Planet Technologies develops a membrane-based process for capturing carbon dioxide from industrial flue gas emissions, targeting industrial emitters including hard-to-abate sectors.
CleantechClimate TechDeep Tech
Co-investorsCRH VenturesEni NextGV (Google Ventures)BlueScopeX
Tr1X is a biopharmaceutical company developing cell and gene therapies to cure autoimmune and inflammatory diseases with high unmet medical need.
BiotechDeep TechHealthtechMedical Devices
David(Co-Founder)Maria Grazia Roncarolo(Co-Founder, President and Head of R&D)
Co-investorsThe Column Group
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






